MarketsNotableSingle-source
5.4
Roche reports 6% H1 sales growth to $37.28 billion, maintains full-year guidance
Valor Econômico·CH·about 23 hours ago
MarketsSingle-sourceLow
2.0
Krka Group H1 2026 Financial Results Release
Krka Group has published its unaudited interim financial report for the first half of 2026. The report details the company's performance metrics, providing data for investors to assess the pharmaceutical firm's growth trajectory and operational efficiency.
Score Breakdown
Mosaic Score2.0
Confidence0.9
Significance0.1
Source credibility0.1
Related signals
8 foundMarketsSingle-source
2.1
GEN-I Group reports 16.7 million euro net profit in H1 2026
Poslovni DnevnikLO·SI·1 day ago
MarketsNotableConfirmed
9.4
Neoenergia Q2 net profit declines 45% year-over-year to R$ 900 million
InfoMoney·BR·2 days ago
MarketsNotableSingle-sourceDeveloping
5.4
Roche H1 revenue growth impacted by CHF strength; FDA decision on breast cancer drug pending
Börsen-Zeitung·CH · US·about 18 hours ago
MarketsNotableSingle-source
5.2
Roche H1 2026 Revenue Declines to 30.4B CHF Amid Currency Headwinds
SRFLO·CH·about 12 hours ago
MarketsSingle-source
2.1
Intershop reports improved earnings despite revenue contraction
Zeit OnlineLO·DE·2 days ago
MarketsSingle-source
2.1
Novartis Q2 earnings exceed projections despite ongoing patent expiration headwinds
Valor Econômico·CH · US·3 days ago
MarketsSingle-source
2.1
Dominion reports tripling of H1 profit with EBITDA at 63.2 million euros
ExpansiónLO·ES·2 days ago